News Headlines Article

New methods needed to cut Rx spending growth: analysis
Modern Healthcare

The rate of U.S. prescription-drug spending growth has declined in recent years, but payers should consider new methods for reducing drug costs, according to an analysis. The National Institute for Health Care Reform published a policy analysis this month that examines the potential of implementing tools used by Australia, the U.K. and other countries to slow prescription-drug spending in the U.S. market.